Top

Published in:

01-01-2012 | Letter to the Editor

Leriche’s syndrome and Löffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome

Authors: Thomas Klag, Ulf Schnetzke, Rudolf Benz, Jürgen Zanow, Anita Glaser, Tudor C. Pörner, Sebastian Scholl, Andreas Reiter, Andreas Hochhaus, Paul La Rosée

Published in: Annals of Hematology | Issue 1/2012

Excerpt

Dear Editor, …

Bain BJ et al. (2008) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRa, PDGFRß or FGFR1. In: WHO classification of tumours of haematopoietic and lymphoid tissue, 68–73. (Lyon) Fourth Edition ed.

Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE et al (2009) Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 124(6):1319–1325, e3PubMedCrossRef

Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348(13):1201–1214PubMedCrossRef

Vandenberghe P, Wlodarska I, Michaux L, Zachee P, Boogaerts M, Vanstraelen D et al (2004) Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia 18(4):734–742PubMedCrossRef

Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL et al (2004) FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 104(10):3038–3045PubMedCrossRef

Roche-Lestienne C, Lepers S, Soenen-Cornu V, Kahn JE, Lai JL, Hachulla E et al (2005) Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia 19(5):792–798PubMedCrossRef

Erben P, Gosenca D, Muller MC, Reinhard J, Score J, Del Valle F et al (2010) Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica 95(5):738–744PubMedCrossRef

Metzgeroth G, Walz C, Erben P, Popp H, Schmitt-Graeff A, Haferlach C et al (2008) Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study. Br J Haematol 143(5):707–715PubMedCrossRef

Sakuta R, Tomita Y, Ohashi M, Nagai T, Murakami N (2007) Idiopathic hypereosinophilic syndrome complicated by central sinovenous thrombosis. Brain Dev 29(3):182–184PubMedCrossRef

10.

Kobayashi M, Komatsu N, Kuwayama Y, Bandobashi K, Kubota T, Uemura Y et al (2007) Idiopathic hypereosinophilic syndrome presenting acute abdomen. Intern Med 46(10):675–678PubMedCrossRef

11.

Jang KA, Lim YS, Choi JH, Sung KJ, Moon KC, Koh JK (2000) Hypereosinophilic syndrome presenting as cutaneous necrotizing eosinophilic vasculitis and Raynaud’s phenomenon complicated by digital gangrene. Br J Dermatol 143(3):641–644PubMedCrossRef

12.

Kawata E, Kuroda J, Wada K, Yoshida M, Kamiuchi K, Nakayama-Harusato I et al (2007) Hypereosinophilic syndrome accompanied by Buerger’s disease-like femoral arterial occlusions. Intern Med 46(23):1919–1922PubMedCrossRef

Title: Leriche’s syndrome and Löffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome
Authors: Thomas Klag
Ulf Schnetzke
Rudolf Benz
Jürgen Zanow
Anita Glaser
Tudor C. Pörner
Sebastian Scholl
Andreas Reiter
Andreas Hochhaus
Paul La Rosée
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: Annals of Hematology / Issue 1/2012
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-011-1232-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Leriche’s syndrome and Löffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level

Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma

Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis

Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia

Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide

Evans syndrome with cytomegalovirus infection followed by emerging peripheral T-cell lymphoma

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page